دورية أكاديمية
Safety and Effectiveness of Portal Vein Embolization after Hepatic Arterial Infusion Therapy.
| العنوان: | Safety and Effectiveness of Portal Vein Embolization after Hepatic Arterial Infusion Therapy. |
|---|---|
| المؤلفون: | Li N; Dotter Interventional Institute, Oregon Health & Science University, Portland, Oregon; Division of Interventional Radiology, Department of Radiology, UMass Chan Medical School, Worcester, Massachusetts., Schwantes IR; Division of Surgical Oncology, Department of Surgery, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Mayo SC; Division of Surgical Oncology, Department of Surgery, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Park B; Dotter Interventional Institute, Oregon Health & Science University, Portland, Oregon., Koethe Y; Dotter Interventional Institute, Oregon Health & Science University, Portland, Oregon; TRG Imaging, Portland, Oregon. Electronic address: yilun.koethe@providence.org. |
| المصدر: | Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2024 Aug; Vol. 35 (8), pp. 1209-1214. Date of Electronic Publication: 2024 May 03. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Society of Cardiovascular and Interventional Radiology Country of Publication: United States NLM ID: 9203369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-7732 (Electronic) Linking ISSN: 10510443 NLM ISO Abbreviation: J Vasc Interv Radiol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Reston, Va. : Society of Cardiovascular and Interventional Radiology, c1990- |
| مواضيع طبية MeSH: | Embolization, Therapeutic*/adverse effects , Portal Vein*/diagnostic imaging , Liver Neoplasms*/therapy , Liver Neoplasms*/diagnostic imaging , Infusions, Intra-Arterial*, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Treatment Outcome ; Aged ; Time Factors ; Liver Regeneration ; Hepatic Artery/diagnostic imaging ; Risk Factors ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects |
| مستخلص: | Portal vein embolization (PVE) is a tool potentially useful for inducing future liver remnant (FLR) hypertrophy in patients with advanced hepatic malignancies who are at high risk of hepatic insufficiency if treated with surgical resection. However, the safety and effectiveness of PVE in the context of patients who have undergone hepatic arterial infusion (HAI) are unknown. This retrospective, single-center study identified 9 patients who underwent PVE after HAI between January 2015 and December 2022. There were no major adverse events, including biliary injury or high-grade liver failure. Analysis showed an increase in standardized FLR from 21.1% (SEM ± 2.4) to 34.8% (SEM ± 2.1) over 9.8 weeks (SEM ± 1.2), with a mean kinetic growth rate of 1.9% (interquartile range, 0.9%-2.4%). Patients who have undergone HAI therapy should not be excluded from consideration of PVE as part of their operative clearance strategy. (Copyright © 2024. Published by Elsevier Inc.) |
| المشرفين على المادة: | 0 (Antineoplastic Agents) |
| تواريخ الأحداث: | Date Created: 20240504 Date Completed: 20240725 Latest Revision: 20240725 |
| رمز التحديث: | 20240726 |
| DOI: | 10.1016/j.jvir.2024.04.020 |
| PMID: | 38704140 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1535-7732 |
|---|---|
| DOI: | 10.1016/j.jvir.2024.04.020 |